1. Home
  2. BAND vs ATYR Comparison

BAND vs ATYR Comparison

Compare BAND & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAND
  • ATYR
  • Stock Information
  • Founded
  • BAND 2000
  • ATYR 2005
  • Country
  • BAND United States
  • ATYR United States
  • Employees
  • BAND N/A
  • ATYR N/A
  • Industry
  • BAND Computer Software: Prepackaged Software
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BAND Technology
  • ATYR Health Care
  • Exchange
  • BAND Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • BAND 358.3M
  • ATYR 290.6M
  • IPO Year
  • BAND 2017
  • ATYR 2015
  • Fundamental
  • Price
  • BAND $14.47
  • ATYR $3.31
  • Analyst Decision
  • BAND Hold
  • ATYR Strong Buy
  • Analyst Count
  • BAND 5
  • ATYR 6
  • Target Price
  • BAND $21.00
  • ATYR $18.60
  • AVG Volume (30 Days)
  • BAND 284.4K
  • ATYR 1.1M
  • Earning Date
  • BAND 05-07-2025
  • ATYR 05-07-2025
  • Dividend Yield
  • BAND N/A
  • ATYR N/A
  • EPS Growth
  • BAND N/A
  • ATYR N/A
  • EPS
  • BAND N/A
  • ATYR N/A
  • Revenue
  • BAND $751,695,000.00
  • ATYR N/A
  • Revenue This Year
  • BAND $1.59
  • ATYR $551.06
  • Revenue Next Year
  • BAND $13.79
  • ATYR $2,144.84
  • P/E Ratio
  • BAND N/A
  • ATYR N/A
  • Revenue Growth
  • BAND 18.51
  • ATYR N/A
  • 52 Week Low
  • BAND $11.33
  • ATYR $1.42
  • 52 Week High
  • BAND $25.02
  • ATYR $4.66
  • Technical
  • Relative Strength Index (RSI)
  • BAND 63.53
  • ATYR 47.21
  • Support Level
  • BAND $11.93
  • ATYR $3.06
  • Resistance Level
  • BAND $15.00
  • ATYR $3.47
  • Average True Range (ATR)
  • BAND 0.48
  • ATYR 0.24
  • MACD
  • BAND 0.33
  • ATYR -0.01
  • Stochastic Oscillator
  • BAND 78.18
  • ATYR 22.95

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: